An Open-Label Uncontrolled, Multicenter Study for the Evaluation of the Efficacy and Safety of the Dermal Filler Princess VOLUME in the Treatment of Nasolabial Folds

Table 2

MFWS grades at each study time point.

Day	NLF	Number (%)^a of subjects with MFWS grade
		0	0.5	1	1.5	2	2.5	3
Day 0; ()	Right	—	—	—	—	30 (62.5)	16 (33.3)	2 (4.2)
	Left	—	—	—	—	26 (54.2)	19 (39.6)	3 (6.3)
Day 14; ()	Right	4 (8.3)	18 (37.5)	19 (39.6)	7 (14.6)	—	—	—
	Left	6 (12.5)	11 (22.9)	24 (50.0)	7 (14.6)	—	—	—
Day 30; ()^b	Right	4 (8.5)	18 (38.3)	22 (46.8)	3 (6.4)	—	—	—
	Left	5 (10.6)	16 (34.0)	24 (51.1)	2 (4.3)	—	—	—
Day 90; ()^b	Right	4 (8.5)	15 (31.9)	25 (53.2)	3 (6.4)	—	—	—
	Left	4 (8.5)	13 (27.7)	27 (57.4)	3 (6.4)	—	—	—
Day 180; ()^b	Right	1 (2.1)	14 (29.8)	25 (53.2)	6 (12.8)	1 (2.1)	—	—
	Left	1 (2.1)	13 (27.7)	26 (55.3)	5 (10.6)	2 (4.3)	—	—
Day 270; ()^b	Right	—	14 (29.8)	20 (42.6)	12 (25.5)	—	—	1 (2.1)
	Left	—	13 (27.7)	23 (48.9)	10 (21.3)	—	1 (2.1)	—

Grade 0 = no wrinkle; Grade 0.5 = very shallow yet visible wrinkle; Grade 1 = fine wrinkle; Grade 1.5 = visible wrinkle and clear indentation; Grade 2 = moderate wrinkle; Grade 2.5 = prominent and visible wrinkle; Grade 3 = deep wrinkle
Percentages are based on the number of subjects with available data.
One subject was lost to follow-up after Day 14.
Safety analysis data set: SAF.
MFWS = Modified Fitzpatrick Wrinkle Scale, = number of subjects with available data, and NLF = nasolabial fold.